Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)

• Paolo Gisondi,
• Alice B. Gottlieb,
• Boni Elewski,
• Matthias Augustin,
• Sandy McBride,
• Tsen-Fang Tsai,
• Christine de la Loge,
• Frederik Fierens,
• José M. López Pinto,
• Nicola Tilt,
• Mark Lebwohl

Affiliations

Paolo Gisondi

Dermatology and Venereology, Department of Medicine, University of Verona

Alice B. Gottlieb

Department of Dermatology, Icahn School of Medicine at Mount Sinai

Boni Elewski

Department of Dermatology, University Hospitals of Cleveland, Case Western Reserve University

Matthias Augustin

Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE)

Sandy McBride

Royal Free London NHS Foundation Trust

Tsen-Fang Tsai

Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine

Christine de la Loge

PCOM Analytics

Frederik Fierens

UCB Pharma

José M. López Pinto

UCB Pharma

Nicola Tilt

UCB Pharma

Mark Lebwohl

Department of Dermatology, Icahn School of Medicine at Mount Sinai